700 patients110,866 observations180 daysLIVE

Patient P-02494

Synthetic patientMETA-24 · Day 177 · 45–54 · M · baseline S09Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
9%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S09
  2. Day 15 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 22 GI-04 recommendedGI Support Protocol GI-04
  4. Day 23 Patient acceptedStarted GI-04 in the companion
  5. Day 31 GI symptom burden −23% vs expectedGI Support Protocol GI-04
  6. Day 37 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 15.

Primary contributors, last 14 days
  • GI instability-18
  • Inflammatory activity-15
  • Nutritional resilience+14
  • Treatment adherence+4

What helped?

  • GI Support Protocol GI-04Day 22
    Result: symptom burden −23%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
41 min
stable · -1.0 vs previous 14 d
Sleep duration
Wearable
7 h
stable · +0.1 vs previous 14 d
Energy level
Daily log
5.7/10
stable · +0.2 vs previous 14 d
Steps
Wearable
4,145
stable · +14 vs previous 14 d
GI burden
Companion
13.7/100
worsening · +1.3 vs previous 14 d
Adherence
Companion
97.9 %
improving · +5.6 vs previous 14 d
Sleep quality
Wearable
52/100
improving · +2.9 vs previous 14 d
Glucose, CGM daily mean
CGM
134 mg/dL
stable · -0.2 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 78 from the failing basin, 31 from restoration.

Good elements to keep
  • GI Support Protocol GI-04
    intervention · steering +15.3
  • Protein (supports)
    perturbation · steering +9.9
  • Daily walks resumed
    perturbation · steering +3.3
  • Protein
    supporter · GI -5.5 next day
Main detractors to watch
  • Low butyrate capacity
    hidden · steering -17.5
  • Dietary fat load
    perturbation · steering -10.5
  • Simple carbohydrates
    perturbation · steering -8.2
  • Low microbial diversity
    hidden · steering -7.7
  • Dietary fat load
    detractor · GI +5.9 next day
  • Simple carbohydrates
    detractor · GI +4.6 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +5.9detractor · 95%
  • Protein
    -5.5supporter · 95%
  • Simple carbohydrates
    +4.6detractor · 95%
  • Ultra-processed food
    +3.6detractor · 75%
  • Histamine load
    +3.3no signal · 48%
  • Caffeine
    -0.8no signal · 15%
  • Alcohol
    +0.8no signal · 15%
  • Insoluble fibre
    -0.7no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 60
    • MicrobiomeButyrate capacity 27/100
    • MicrobiomeF. prausnitzii depleted
  • Mucosal barrier integrity 30
    • MicrobiomeAkkermansia low → thinner mucus layer
  • Inflammatory signalling 20
    • MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Intermediate metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.9 · butyrate capacity 27/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
49 ms
Sleep
6.8 h
Steps
4,747
Resting HR
69 bpm
Daily log: GI score 14, nutritional resilience 69, adherence 98.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0228543%S14AD-05no change39
P-0203140%S12AD-05improved47
P-0209338%S05AD-05no change40
P-0226745%S09BR-03no change45
P-0208740%S01BR-03no change40
P-0252238%S01BR-03no change40
P-0228036%S07BR-03no change50
P-0243934%S08BR-03no change40
P-0248334%S06BR-03no change64
P-0263834%S01BR-03improved41
P-0245556%S09DT-01improved50
P-0223550%S14DT-01improved50